Overview

Advance Neurological Care with Precision Pharmacogenomics

Personalize treatments for complex neurological conditions, reduce medication side effects, and enhance patient outcomes across your health system.

Schedule a Demo Contact us

Overview

Neurological disorders vary widely in presentation and therapeutic needs. PGxAI's Neurology module (PGxNeuronis™) harnesses advanced pharmacogenomics and real-time data analytics to tailor medication regimens for conditions like epilepsy, Parkinson's, Alzheimer's, and chronic pain. By merging genetic markers, clinical insights, and machine learning, PGxNeuronis™ helps neurologists optimize therapies, minimize side effects, and improve long-term patient outcomes.

•

80+ neurological drugs covered, from antiepileptics to migraine treatments.

•

46 key genetic markers informing dose adjustments and drug selection.

•

AI-driven recommendations that adapt to each patient's evolving clinical picture.

Key Highlights

Serving every stakeholder in healthcare

Schedule a Demo Contact Us

Comprehensive Drug-Gene Insights

Tailors therapy choices for antiepileptics, movement disorder medications, and more.

Reduced Adverse Effects

Genetic-based dosing helps lower risks like sedation, cognitive impairment, or movement-related side effects.

Enhanced Chronic Care Management

Longer-term tracking of therapeutic responses, supporting better planning for progressive conditions.

Reimbursable Testing

Aligns with recognized CPT codes, ensuring a cost-effective approach to personalized neurology care.

Clinical Impact

Maximize Clinical Impact with PGxAI

Schedule a Demo Contact Us

Precision-Guided Therapy Optimization

PGxAI mines genotype, phenotype, and comorbidity data in real time to recommend the optimal drug–dose pair at the first prescription. By accounting for actionable allelic variants and metabolic phenotypes, it minimizes trial-and-error titration and sharply reduces severe drug–gene and drug–drug interactions.

Superior Patient Outcomes & Experience

Genomically informed prescribing lowers adverse-event rates, accelerates therapeutic response, optimizes co-administered medications and boosts adherence. Patients spend less time managing side effects and more time benefiting from treatment, enhancing both clinical endpoints and satisfaction metrics across specialties.

Demonstrable Value-Based Performance

Fewer complications, shorter lengths of stay, and reduced readmissions translate into measurable gains on CMS and private-payer quality dashboards. Institutions leveraging PGxAI can document higher quality scores and capture value-based reimbursement upside while lowering total cost of care.

Seamless Team Integration & Scalability

The platform embeds directly into leading EHRs and e-prescribing systems, delivering concise, guideline-aligned reports that support rapid decision-making for multidisciplinary teams. Standardized APIs and CDS hooks allow effortless expansion from pilot units to enterprise-wide deployment without workflow disruption.

Drug Categories

PGxAI supports a range of respiratory therapies

Schedule a Demo Contact Us

Antiepileptic Drugs (AEDs):

Phenytoin, Valproic Acid, Lamotrigine

Targeted Therapies:

Donepezil, Rivastigmine, Memantine

Pain Management:

Opioids (Morphine, Fentanyl), Tramadol, Gabapentin

Migraine Treatments:

Triptans (Sumatriptan, Eletriptan), CGRP inhibitors

Muscle Relaxants & Anesthetics:

Tizanidine, Succinylcholine, Propofol. Each recommendation draws on validated genetic markers (e.g., CYP2C9, CYP2D6, CACNA1C) and real-world outcome data.

Case Study

Evergreen Neurology Center

Schedule a Demo Contact Us

Challenge

High rates of drug-resistant epilepsy and frequent ER visits.

Solution

PGxAI deployed to analyze patient genetics for optimal AED selection and dosing.

Results

25% reduction in breakthrough seizures over 6 months, fewer adverse events, and increased patient adherence.

What's next

Ready to Shape the Future of Precision Medicine?

Empower your neurology teams with AI-driven pharmacogenomics that reduce adverse events, improve quality of life, and optimize resource utilization.

Request a Demo

See how PGxNeuronis™ integrates into your neurology workflow.